Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05934773Not ApplicableTerminated

Post-Brain Injury Walking and Balance Recovery Program

Role: collaborator

NCT00957671Phase 4Completed

Anterior Pituitary Hormone Replacement in Traumatic Brain Injury

Role: collaborator

NCT02113124Completed

Association of Amino Acid Prevalence and Chronic Brain Injury

Role: collaborator

NCT01495871Not ApplicableWithdrawn

Amino Acid Supplementation in Recovery From Traumatic Brain Injury

Role: collaborator

All 4 trials loaded